September 11, 2019
Myia Labs has raised $10 million in a Series A funding round led by Mercy Virtual, which pledged $5 million after deploying the startup’s AI and consumer wearable monitoring platform among its patients over the last few years.
Other investors in the round include Zetta Venture Partners, BootstrapLabs, Boston Consulting Group and B Capital Group, all of which participated in last year’s $6.75...
August 8, 2019
Sensors from consumer-grade devices like iPhones, Apple Watches, iPads and Beddit sleep monitors capture enough data to spot mild cognitive impairment or Alzheimer’s disease dementia, according to a new feasibility study conducted jointly by Apple, Eli Lilly and Company and Evidation Health researchers that was presented today at a research conference held in Anchorage, Alaska.
“Over the past few...
July 31, 2019
Litmus Health announced yesterday the release of a new version of its device-friendly clinical research platform for the collection and analysis of real-world data.
Built with new features to help pharmaceutical companies from the beginning to the end of their drug trials, the platform now adds Actigraph’s medical-grade wearables to its repertoire of supported devices, which previously included...
April 9, 2019
Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses, is racking up the pharma partnerships as of late. Just weeks after the artificial intelligence company agreed to a multi-year deal with Bristol-Myers Squibb, Concerto announced this morning a similar project with Pfizer that will support the latter’s research on precision oncology...
March 29, 2019
Bristol-Myers Squibb’s research efforts will be getting an artificial intelligence boost thanks to a new multi-year deal signed by the pharmaceutical company and Concerto HealthAI, the maker of a clinical insight generation platform that employs real-world data in its analyses.
According to the announcement, Concerto’s eurekaHealth tool will “accelerate insights through novel health economic...
February 5, 2019
New York City-based Aetion, which makes an analytics platform to assess real-world evidence from a range of sources, has raised $27 million in a funding round supported by new backers Sanofi, UCB, McKesson Ventures and Horizon Health Services, according to a release. Prior investors including NEA, Flare Capital and Lakestar also participated.
An add-on to prior funding from last year, today’s...
February 16, 2017
Vienna and San Diego-based digital health company mySugr has come out of the International Conference on Advanced Technologies and Treatments for Diabetes with two big pieces of news: study results that show impressive efficacy of the app in high-risk populations and an expansion of its partnership with Roche.
The study looked at 440 mySugr users randomly selected from a group of high-risk (HbA1C...